Brief assessment of cognition in schizophrenia: validation of the Japanese version.
about
Profile of blonanserin for the treatment of schizophreniaCriterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophreniaImpaired musical ability in people with schizophrenia.Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.Brain structural changes and neuropsychological impairments in male polydipsic schizophrenia.Differential effects of the catechol-O-methyltransferase Val158Met genotype on the cognitive function of schizophrenia patients and healthy Japanese individualsEffect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia.Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.LORETA current source density for duration mismatch negativity and neuropsychological assessment in early schizophreniaLong-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study.Association of the Hermansky-Pudlak syndrome type 4 (HPS4) gene variants with cognitive function in patients with schizophrenia and healthy subjects.Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia).Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial.The Chinese Version of the Brief Assessment of Cognition in Schizophrenia: Data of a Large-Scale Mandarin-Speaking Population.Neurocognitive features in male patients with schizophrenia exhibiting serious violence: a case control studyComparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia.Electrophysiological and neuropsychological predictors of conversion to schizophrenia in at-risk subjects.Association of fronto-temporal function with cognitive ability in schizophreniaBlood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia.Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function.Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone.Association between the scores of the Japanese version of the brief assessment of cognition in schizophrenia and whole-brain structure in patients with chronic schizophrenia: a voxel-based morphometry and diffusion tensor imaging study.Association of Polymorphisms of the Receptor for Advanced Glycation Endproducts Gene with Schizophrenia in a Han Chinese Population.Cost-effectiveness of cognitive remediation and supported employment for people with mental illness: a randomized controlled trial.Associations between daily living skills, cognition, and real-world functioning across stages of schizophrenia; a study with the Schizophrenia Cognition Rating Scale Japanese version.Omega-3 fatty acids related to cognitive impairment in patients with schizophrenia.Association between cognitive deficits and suicidal ideation in patients with major depressive disorder.PCLO rs2522833-mediated gray matter volume reduction in patients with drug-naive, first-episode major depressive disorderCognitive clustering in schizophrenia patients, their first-degree relatives and healthy subjects is associated with anterior cingulate cortex volume.Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia.Immunoglobulin genotypes and cognitive functions in schizophrenia.The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: a preliminary open-label trial.Cognitive impairments in psychotic disorders: common mechanisms and measurement.Neurocognitive functioning in patients with first-episode schizophrenia 1 year from onset in comparison with patients 5 years from onset.A pilot study: comparative research of social functioning, circadian rhythm parameters, and cognitive function among institutional inpatients, and outpatients with chronic schizophrenia and healthy elderly people.The effects of adjunctive intranasal oxytocin in patients with schizophrenia.Effects of cognitive remediation on cognitive and social functions in individuals with schizophrenia.Olfactory deficits in individuals at risk for psychosis and patients with schizophrenia: relationship with socio-cognitive functions and symptom severity.Cognitive function, treatment response to lithium, and social functioning in Japanese patients with bipolar disorder.Association between social functioning and prefrontal cortex function during a verbal fluency task in schizophrenia: A near-infrared spectroscopic study.
P2860
Q24614169-8C94DB43-CF39-43CE-867D-08120E0C01EAQ28744227-B45E680C-379D-4C7C-84B5-D7D68B310A5CQ30354449-1EA49A20-D420-4DD4-9162-3BFDDDAC982AQ30458919-6A339126-278C-4289-AF0F-D9FE26D57643Q30578538-C8AA92F4-3E2C-4627-ADDF-7E7F8B153A78Q31144520-BF31E8BF-E9E8-4D4F-B4BA-189AD7E32ACDQ34249753-D4C3FD1B-5A3D-4CCE-9CB3-2F2660FA0013Q34523396-6707847E-2BEC-4BF4-8FF1-B74876E37B1CQ34664140-F83DF4C1-3C7E-456C-9D5D-6531748745ACQ35021026-B55AE4CC-8C80-4BD0-B1D7-E41C32BA9311Q35028101-9BB593FB-5DA3-4257-8975-C3961A311164Q35565312-67B12B44-6E20-4732-8C96-4EEFBF3B55B3Q36033253-39260FC9-2966-4564-9F8F-B087A74AE32AQ36353635-98AC1557-82B8-4329-BE79-63D3C2503E3CQ36393831-D31A8280-E865-4F38-9077-1DF018FD3492Q37106851-B6137E7D-1DCB-499B-BDA2-03991EAD1DE6Q37240723-CCE5E3BC-D6D3-4207-9AF2-4F0581F90EF7Q37644224-6BC9C145-9C2A-4209-A4A8-268A1C61ED0AQ37729158-1F39EABC-E41B-4DAD-A1C1-E796E8FB71DCQ38150484-1347079E-A2E9-4AEA-918C-1B70D78C89FFQ38582539-2E8B537F-9844-4472-A6C2-E4B8CC81B10AQ38654060-E94E6041-95B5-43D7-A389-93509127E157Q38857262-1DEC6AC6-B037-47CA-B7C6-D7EFA6FEFD10Q39365321-D6BE2008-2A19-41FA-82B5-C290C03CE5F6Q40109696-AD17BC4E-F3F8-4F57-8DAF-E477A6FAB372Q41040716-919F8ED4-4B0A-44F3-A405-93CE63D3D86DQ41046578-DD39E134-04EE-445D-96BF-6868427D0522Q41173109-08D6E4F8-6C0E-4030-808F-D72817B39326Q41375198-5EEE5922-F9A4-442D-BD0B-8D81EDBEED30Q41678697-F6D87144-6CEE-47A9-A5F7-54813AFE66EDQ41932362-7ADB7FEE-951A-4D44-B15A-2F14035AE934Q42618887-CD6EC84A-6F49-4CEC-8924-95AC8D080AF7Q42973967-9E063470-7F35-4FA6-885B-9BD75ED051F9Q45014400-42A470D1-0935-4215-8C46-B7EEF789C850Q45854457-A8580953-8E17-499E-9B67-F1B02F0CB8F6Q47580425-78F98D81-FF60-4132-8528-0D59DB9709E0Q47584664-329B3318-BB7B-486B-81B6-105FF1066FBDQ47588792-38FAA578-36E8-4AE8-BE02-2D82B516376FQ47673229-5C382F03-A128-4DB4-95EC-23E68C45D34BQ47804504-B98DBC90-D49A-4591-8CB0-445D2792F4D6
P2860
Brief assessment of cognition in schizophrenia: validation of the Japanese version.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Brief assessment of cognition in schizophrenia: validation of the Japanese version.
@en
Brief assessment of cognition in schizophrenia: validation of the Japanese version.
@nl
type
label
Brief assessment of cognition in schizophrenia: validation of the Japanese version.
@en
Brief assessment of cognition in schizophrenia: validation of the Japanese version.
@nl
prefLabel
Brief assessment of cognition in schizophrenia: validation of the Japanese version.
@en
Brief assessment of cognition in schizophrenia: validation of the Japanese version.
@nl
P2093
P2860
P1476
Brief assessment of cognition in schizophrenia: validation of the Japanese version.
@en
P2093
Richard Keefe
Shusuke Numata
Tetsuro Ohmori
Tomiki Sumiyoshi
Yasuhiro Kaneda
Yasuhito Ishimoto
P2860
P304
P356
10.1111/J.1440-1819.2007.01725.X
P577
2007-12-01T00:00:00Z